ISTH 2017 Invitation and Welcome Message
We are pleased to welcome you to the XXVI International Society on Thrombosis and Haemostasis (ISTH) Congress and 63rd Annual Scientific and Standardization Committee (SSC) Meeting in Berlin, a city full of life with a distinctive culture and cosmopolitan blend of people and events. Founded in the 13th century, Berlin has experienced an eventful history, […]
ISTH 2017 in the Palm of Your Hand: Download the Congress App!
Download the official ISTH 2017 Congress App today and gain access to the program and your personal itinerary on the go. See abstracts, presenters, exhibition information, maps, news and more from the palm of your hand. The ISTH 2017 Congress App is an essential tool to navigate all aspects of the meeting. Click here to […]
New SSC Subcommittee Meets for the First Time in Berlin
The new SSC Subcommittee on Perioperative Thrombosis and Hemostasis will hold its inaugural meeting as an official Subcommittee at the ISTH 2017 Congress in Berlin.
Don’t Miss the Special World Thrombosis Day Session on Sunday Afternoon
Did you know that one in four people worldwide die of conditions caused by thrombosis? Dive into this compelling and timely topic by attending the upcoming session, “World Thrombosis Day: Building Awareness and Elevating Impact for the Global Burden of Thrombosis”
What to See, Do and Eat in Berlin: An ISTH 2017 Visitors Guide
Berlin is the capital of Germany as well as its largest city. An international business hub, Berlin is a popular destination for professionals as well as tourists. The city is known for its distinctive history, modern economy, diverse architecture and high quality of living. As the ISTH 2017 Congress takes place during peak summer tourism season, the city will be alive with a cosmopolitan mix of people and events.
New Open Access Journal, RPTH, Publishes Inaugural Issue at ISTH 2017
The ISTH, in partnership with John Wiley and Sons, Inc., announces the launch of the Society’s new open access journal, Research and Practice in Thrombosis and Haemostasis (RPTH), with its inaugural issue to publish in conjunction with the ISTH 2017 Congress.
ISTH 2017 Travel Award Recipients
Congratulations to the following recipients of travel awards to the ISTH 2017 Congress. Travel award recipients should visit the Travel Award desk in the Registration Area on the main entrance level of the CityCube Berlin to receive their grant.
Get Your Virtual Delegate Bag with Unique Offers and Promotions
In addition to traditional delegate bags, all ISTH 2017 attendees have access to virtual delegate bags online this year. Access your virtual delegate bag to take advantage of unique offers, discounts and promotions from supporters.
Plan to Attend the Reach-the-World and WFH Fellowships Symposium
Join the ISTH and the World Federation of Hemophilia (WFH) for a special session, “Building Capacity Globally: The Impact and Future of the RtW and IHTC Programs”
Watch Selected ISTH 2017 Sessions Live Online
If you can't make it to Berlin (or even if you did!), you can join us online for a FREE live broadcast of selected sessions from the ISTH Congress.
Stop by the ISTH Booth for the Latest Offerings, Giveaways and More!
Visit the ISTH booth, no. 200 in Hall 2.2, to meet the ISTH staff and learn more about the Society’s educational initiatives, future meetings and publications.
Visit Supported Symposia and Product Theaters for Latest Updates
Complementing an exciting and innovative scientific program, ISTH 2017 features the latest diagnostic and therapeutic updates from the leading companies in the field of thrombosis and hemostasis.
View the ISTH 2017 Abstracts Online
Abstracts are now available as a special compilation from Research and Practice in Thrombosis and Haemostasis (RPTH), the new open access journal of the ISTH. Access abstracts here or view via the online program. Note on Late Breaking Abstracts: Full text of Late Breaking Oral Abstracts will be released via the mobile app and online program after they are presented.
Download the New ISTH Academy App for Education on Demand
Download the new ISTH Academy App today and gain access to select recorded ISTH 2017 presentations, as well as archived webinars and webcasts from previous meetings.
Past, Present, and Future SSC Chairs Highlight Important Sessions
In preparation for the 63rd Annual Scientific and Standardization Committee Meeting at the ISTH 2017 Congress, we asked the past, present and future SSC Chairmen to pick the most interesting SSC Subcommittee presentations.
#ISTH2017: Join the Conversation Online
Connect with the ISTH and your peers online to broaden the conversation before, during and after ISTH 2017. Use #ISTH2017 in your social media posts to share your thoughts and learn what others are thinking.
ISTH 2017 Networking Evening
The ISTH is delighted to invite you to the official ISTH 2017 Congress Networking Evening on Wednesday, July 12 at 19:00. Join us for this exciting event at the visionary and unique Tempodrom where you will have the opportunity to network with friends and colleagues. The evening will feature musical performances from local artists as well as […]
ISTH 2017 5K Charity Run/Walk
Keep Life Flowing – benefiting World Thrombosis Day Tuesday, July 11 at 8 p.m. – Grunewald Register Now The participation fee is 10 EUR and all proceeds will benefit World Thrombosis Day. Join us for the ISTH 2017 5K Charity Run/Walk on Tuesday July 11 at 8 p.m.. Stay fit and help raise awareness and support ISTH’s global World […]
Plenary Agenda is Now Available!
ISTH 2017 Congress President Johannes Oldenburg Welcomes Attendees
ISTH 2017 Congress President Johannes Oldenburg, M.D., Ph.D. personally welcomed attendees to Berlin. The Congress this year is the largest, most impressive meeting to date, with more than 130 invited speakers, 28 State-of-the-Art Sessions, 8 Plenary Sessions, numerous abstracts and symposia, and more than 550 presentations.
Largest Ever ISTH Congress Begins with Exciting Opening Ceremony
ISTH 2017 Congress President Johannes Oldenburg, M.D., Ph.D., officially opened the Congress with a welcome speech followed by a welcome symphony and video presentation. With more than 9,000 registered attendees, the ISTH 2017 Congress was officially hailed as the largest meeting in the history of the ISTH.
Explore New Educational Offerings in the ISTH Academy
Claire McLintock, M.D., ISTH Secretary/Council Chairman-Elect and the Chair of the ISTH Education Committee, stopped by the ISTH TV studio to tell us more about this exciting educational resource.
ISTH Early Career Task Force Invites Participation, Collaboration
The ECTF consists of a group of 12 early career ISTH members from worldwide origins. The ISTH Early Career Task Force (ECTF) invites early career professionals to connect and collaborate at the ISTH 2017 Congress.
Participate in the Exhibition Passport Program and Win Prizes
Would you like to get the most out of your exhibition visits? Make your ISTH 2017 experience even more fun and engaging by visiting the 20+ participating exhibitor booths of the Passport Program. Engage with exhibitors and learn about their products, services and solutions.
SSC Chair Walter Ageno Recaps ISTH 2017 SSC Sessions
On Sunday, the chairman of the Scientific and Standardization Committee (SSC), Walter Ageno, M.D. discussed the role of the committee within the Congress.
Editor-in-Chief Mary Cushman Applauds Launch of RPTH Journal
Mary Cushman, M.D., M.Sc. presented the launch of the Research and Practice in Thrombosis and Haemostasis (RPTH) journal yesterday. The RPTH journal is an online-only, open-access (non-subscription based) publication.
World Thrombosis Day Builds Awareness and Elevates Impact for the Global Burden of Thrombosis
In Sunday’s education session, “World Thrombosis Day: Building Awareness and Elevating Impact for the Global Burden of Thrombosis,” supporters and activists of the World Thrombosis Day campaign joined together to discuss trending topics, key challenges, and what lies ahead for the campaign.
Jack Hirsh Awarded the Prestigious Grant Medal at Opening Ceremony
In a video message shown at the Opening Ceremony of the ISTH 2017 Congress, Jack Hirsh, M.D., accepted the Robert P. Grant Medal, the highest award of the ISTH.
Sam Schulman Announced as Roberts Medal Recipient for SSC Contributions
At the ISTH 2017 Congress Opening Ceremony, the ISTH announced Sam Schulman, M.D., as the Harold R. Roberts Medal recipient, recognizing contributions to the Scientific and Standardization Committee (SSC).
ISTH Awards Three Reach-the-World Fellowships
In February, the ISTH Education Committee awarded three ISTH members with Reach-the-World Fellowships.
Ten Receive BACH Awards Recognizing High Achievement
ISTH Council Chair Ingrid Pabinger, M.D., announced the ten recipients of the Biennial Awards for Contributions to Hemostasis (BACH) during the Opening Ceremony of the ISTH 2017 Congress.
Nurses Committee Chair Maura Malone Discusses Nurses Forum
Maura Malone, MSN, RN highlighted the ISTH Nurses Forum held here at the Congress yesterday. The key areas of focus of the Nurses Forum this year are improving outcomes for patients and families, providing opportunities where nurses can contribute to research, providing education for diverse patient populations (including adolescents), and learning about transitioning care in the clinics.
ISTH 2017 – Sunday Headlines
Guten Tag! That’s how to say “Good day!” in German, and Sunday, July 9, at ISTH 2017 will definitely be a good day. Here is a look at what is in store for you at the International Society on Thrombosis and Haemostasis (ISTH) 2017 Congress. First, a couple of helpful reminders: Be sure to stop […]
Plan to Attend the Reach-the-World and WFH Fellowships Symposium
Join the ISTH and the World Federation of Hemophilia (WFH) for a special session, “Building Capacity Globally: The Impact and Future of the RtW and IHTC Programs”
Novel Functions of VWF – VWF in Tumor Thrombophilia and Metastasis
In Monday’s Joint ISTH-WFH State-of-the-Art Session, “Novel Functions of VWF”, Stefan Schneider, M.D. discussed the role of von Willebrand Factor (VWF) in coagulation and its link to cancer
Efficacy, Safety and Pharmacokinetics (PK) of Emicizumab (ACE910) Prophylaxis (Px) in Persons with Hemophilia A with Inhibitors (PwHAwI): Randomized, Multicenter, Open-label, Phase 3 Study (HAVEN 1)
During Monday’s ISTH 2017 Abstract Symposia Session, ISTH President Johannes Oldenburg, M.D., Ph.D., presented results from the pivotal HAVEN 1 clinical trial.
JTH Editors Discuss New JTH Editors Awards, New Initiatives
Congratulations to the winners of the 2017 Journal of Thrombosis and Haemostasis Editors’ Awards. Five young first authors of these papers received a travel grant to attend the Congress.
Efficacy, Safety and Pharmacokinetics (PK) of Once-weekly Prophylactic (Px) Emicizumab (ACE910) in Pediatric (< 12 years) Persons with Hemophilia A with Inhibitors (PwHAwI): Interim Analysis of Single-arm, Multicenter, Open-label, Phase 3 Study (HAVEN 2)
During Monday’s Oral Session of Hemorrhagic Disorders: Pediatric Aspects, Guy Young, M.D. presented interim results from the pivotal HAVEN 2 clinical trial.
External Validation of a Prognostic Score for Occult Cancer in Patients with Venous Thromboembolism
Luis Jara-Palomares, M.D., Ph.D. presented the results of the external validation of this prognostic score using the RIETE database in a subsequent cohort of patients.
External Validation of a Risk Score for Occult Cancer in Patients with Unprovoked Venous Thromboembolism: Results from an Individual Patient Data Meta-Analysis
A prediction score to identify VTE patients at increased risk of an occult cancer diagnosis was recently proposed. At yesterday’s Cancer Associated Thrombosis: Risk Prediction Oral Session, Nick van Es, M.D. presented the results of an analysis testing this score across several metrics.
Why is ISTH Membership Important? Featuring ISTH Council Chair Ingrid Pabinger
Ingrid Pabinger, M.D., ISTH Council Chair, explained the importance of ISTH membership and becoming part of the ISTH family. She also described many new advantages and programs ISTH is offering, including their new open access journal Research and Practice in Thrombosis and Haemostasis (RPTH).
Life and Death of Platelets – Proinflammatory Function of Dying Platelets
During Monday’s State-of-the-Art Session, Shaun Jackson, M.B.B.S., B.Med.Sci., Ph.D. presented his work on “Proinflammatory Function of Dying Platelets”, describing how these platelets are responsible for heterogenous disorders.
What Happens After Acute VTE? – Chronic Thromboembolic Pulmonary Hypertension
Monday’s State-of-the-Art Session, “What Happens After Acute VTE?” included an important discussion about chronic thromboembolic pulmonary hypertension (CTEPH) led by Irene Lang, M.D.
World Thrombosis Day Chairman Shares Campaign Impact and What’s Ahead
Gary Raskob, Ph.D., Chair of the Steering Committee for World Thrombosis Day sat down with ISTH TV to talk about the campaign’s efforts to raise global awareness of thrombosis.
Former Reach-the-World Fellow Describes Impact of Program
Dr. Patricia Casais, M.D., Ph.D., a former Reach-The-World Fellow, describes the impact of the program on her career, both professionally and personally.
Development and External Validation of a Risk Assessment Model for Cancer-Associated Venous Thromboembolism
On Monday at the 2017 ISTH Congress, Ingrid Pabinger, M.D., ISTH Council Chair, presented the results of the development and validation of a cancer-related venous thromboembolism (VTE) risk assessment model to the Oral Communication Session attendees.
Novel Functions of VWF – VWF and Inflammation
On Monday, during the Joint ISTH-WFH Session on Novel Functions of Von Willebrand factor (VWF), Cecile Denis, M.D. discussed the importance of VWF in inflammation.
What Happens After Acute VTE? – Prevention and Treatment
During Monday’s State-of-the-Art Session titled “What Happens After Acute VTE?”, Arina ten Cate-Hoek, M.D., Ph.D. presented research regarding prevention and management of the post-thrombotic syndrome (PTS)
Monday Headlines Preview – ISTH 2017
Monday marks the start of the plenary sessions. These daily informative discussions kick off with ISTH Council Member Steve Watson, Ph.D., of Britain’s Institute of Cardiovascular Sciences. Watson will be speaking at the Marion I. Barnhart Memorial Lecture on Platelet Signaling with his presentation entitled, “Snakes and Ladders: Identify New Roles for Platelets in Health […]
Hundreds of Congress Attendees Run for Charity
More than 300 ISTH 2017 Congress attendees participated in the ISTH 2017 5K Charity Run/Walk on Tuesday night in Berlin’s Grunewald forest.
Final Results of RE-VERSE AD Study: Reversal of Dabigatran by its Specific Reversal Agent Idarucizumab in Patients with Uncontrolled Bleeding or Requiring Urgent Surgery/Procedures
Charles Pollack, M.D. presented the findings from the RE-VERSE AD study at Tuesday’s Late-Breaking Abstract Session.
Interim Results from a Phase 1/2 AAV5-FVIII Gene Transfer in Patients with Severe Hemophilia A
In a Late-Breaking Session on Tuesday, John Pasi, Ph.D., F.R.C.P., F.R.C.Path. revealed results of the first successful gene transfer in humans for the treatment of severe HA.
Novel Therapies for Hemophilia – Gene Therapy Replacement
During Tuesday’s State-of-the-Art Session “Novel Therapies for Hemophilia”, President and Chief Scientific Officer of Spark Therapeutics, Katherine High, M.D., Ph.D. summarized findings from their phase I/II trial of the long-term safety and efficacy of factor IX (FIX) gene therapy in patients with hemophilia B
Apply for an ISTH Training Fellowship to Gain Global Experience
If you wish to study at an institute known for their expertise in thrombosis and hemostasis, apply for an ISTH Training Fellowship
ISTH SSC 2018 President Dermot Cox Invites You to Dublin
Dermot Cox, Ph.D. previews next year’s 2018 ISTH SSC Congress that will take place in his hometown of Dublin, Ireland.
Join the ISTH for a New Education Workshop in Bangkok
You're invited to the ISTH Workshop on Thrombosis and Hemostasis in Bangkok, Thailand. This workshop is designed to offer the latest training in coagulation and bleeding disorders management.
Access Recorded Presentations from the ISTH Academy and Academy App
All ISTH 2017 attendees can access every Plenary and State-of-the-Art session online for free, available 24 hours after presented via the ISTH Academy and ISTH Academy App
Novel Therapies for Hemophilia – Small Molecules in the Treatment of Hemophilia
During yesterday’s State-of-the-Art Session, Steven Pipe, M.D. presented an overview of the current and future state of small molecules in the treatment of hemophilia. These new therapies are very exciting, as they represent a paradigm shift not seen since the advent of the first replacement products and prophylactic therapy.
Angiogenesis Revisited: Role and (Therapeutic) Implications of Endothelial Metabolism
Vascular endothelial growth factor and Notch are important in angiogenesis, but what has been largely overlooked is the role and therapeutic potential of endothelial cell (EC) metabolism. In Tuesday’s Fritz Koller Plenary Lecture, Peter Carmeliet, M.D., Ph.D. revealed his key research findings.
Stem Cell Engineering – Large-Scale Production of Platelets: A Clinical Perspective
At Tuesday’s State-of-the-Art Session “Stem Cell Engineering”, Cedric Ghevaert, M.D., Ph.D. presented a new approach to the in vitro development of platelets
The IDEAL DVT Study, Individualised Duration of Elastic Compression Therapy against Long-term Duration of Therapy for the Prevention of Post-thrombotic Syndrome: A Randomised Controlled Trial
At yesterday’s Late Breaking Abstract Session, Arina ten Cate-Hoek, M.D., Ph.D. presented results from the IDEAL DVT study.
Current Pathophysiological Concepts of Thrombotic Microangiopathies – New Treatments of TTP
Dr. Cataland describes the role of ADAMTS13 in TTP and presented two important TTP clinical trial
Help Break a Guinness World Records Title
Join the ISTH, World Thrombosis Day and Time2Move in an attempt to break a Guinness World Records title for the most people participating in a chair-based exercise class on Wednesday, July 12 at 17:40 in Hall B following the Erwin Deutsch Plenary Lecture
ISTH 2019 President Robert Medcalf Previews the Congress in Melbourne
Robert Medcalf, Ph.D. previews the upcoming 2019 ISTH Congress that will take place in Melbourne, Australia.
Stem Cell Engineering – Megakaryocyte Matrix Interactions and Platelet Production
At Tuesday’s State-of-the-Art Session, “Stem Cell Engineering”, Alessandra Balduini, M.D. presented her research on megakaryocyte matrix interactions and platelet production
Tuesday Headlines Preview – ISTH 2017
Do you know an early career professional? Are you one yourself? The Early Career Task Force (ECTF) is a group geared toward connecting like-minded colleagues at the ISTH 2017 Congress. You can visit members of the early professionals group at their ISTH Booth (#200) during breaks. Here is a link to the ECTF webpage. You […]
Factor XI and XII in Blood Clotting and Beyond – Factor XII and the Contact System
During Wednesday’s State-of-the-Art Session, Thomas Renné, M.D., Ph.D. presented his fascinating work on “Factor XII and the Contact System”
Factor XI and XII in Blood Clotting and Beyond – Contact Pathway Under Flow
Owen McCarty, Ph.D. presented his research on “Factor XI and XII in Blood Clotting and Beyond: Contact Pathway Under Flow” at Wednesday’s State-of-the-Art Session
Platelets Beyond Thrombosis – Platelets and Their Role as Mediators of Immunity
During Wednesday’s State-of-the-Art Session, Platelets Beyond Thrombosis, John W. Semple, Ph.D. highlighted the attributes of platelets and their precursor cells, megakaryocytes (MK) in their ability to modulate immunity, particularly via their major histocompatibility complex (MHC) class I molecules
Neurobiology and Stroke – Stroke Models: Time for a Compromise
In this State-of-the-Art Session entitled, “Neurobiology and Stroke-Stroke Models: Time for a Compromise”, Denis Vivien, M.D., Ph.D. discussed two stroke models being studied in his laboratory.
Tissue Factor Biology – Tissue Factor Flip-Flopping Between Coagulation and Signaling
Wolfram Ruf, M.D. presented “Tissue Factor Flip-Flopping Between Coagulation and Signaling” at Wednesday’s Plenary Session, providing a detailed assessment of the role of tissue factor (TF) in thrombotic, hemostatic, and immune pathways.
Platelets Beyond Thrombosis – Platelets at the Vascular Interface
At Wednesday’s State-of-the-Art Session, “Platelets Beyond Thrombosis”, Wolfgang Bergmeier, Ph.D., presented ISTH attendees with a review of the literature on RAP1 signaling in platelets as well findings from his most recent research
Venous Thromboembolism in Acute Leukemia: Improved Survival with Anticoagulation
During Tuesday’s Abstract Symposia, Travis Cox, M.D. presented his work evaluating the effect of anticoagulation on survival in patients with venous thromboembolism (VTE) in the setting of acute leukemia and thrombocytopenia
Neurobiology and Stroke – Coagulation and Fibrinolysis at the Neurovascular Interface
Katerina Akassoglou, Ph.D. discussed with attendees at Wednesday’s State-of-the-Art Session her group’s research evaluating fibrin in neurological diseases
Wednesday Headlines Preview – ISTH 2017
Bring together the real world and the virtual world. Have you gotten your virtual bag yet? All ISTH 2017 attendees receive a traditional delegate bag. But this year, everyone is also given exclusive access to a virtual delegate bag online. This gives every attendee the opportunity to take advantage of unique offers, promotions, and discounts […]
Discover the Highlights of ISTH 2017
Watch this video for a brief recap of the Congress, and begin planning to join us in Dublin for the ISTH SSC 2018 meeting, July 18-21, 2018
Von Willebrand Factor-Platelet Microthrombi Phagocytosis by Macrophages as a New Homing Mechanism for Tissue Entry and Fibrosis
During Thursday’s Platelets and Inflammation Oral Session, Nicolas Prévost, Ph.D. presented findings of his study on the existence of distinct tumor-associated macrophages
Improving the Therapeutic Index with JNJ-375: A Novel Long Acting Exosite-1 Thrombin Inhibitor In Animal Models
At Thursday’s DOACs and Beyond - Translational Aspects Oral Session, Madhu Chintala, Ph.D. presented results from his study of JNJ-375, an investigational antithrombotic drug, in animal models
Visualising LPS-Induced Platelet Adhesion And Activation in Lungs Using Immunohistochemistry
At the Thursday Platelets and Inflammation Oral Session, Simon Cleary, Ph.D. presented a study of platelet responses in the mouse lung microcirculation
Pharmacokinetic and Pharmacodynamic Modeling of Andexanet Alfa Dose to Reverse the Anticoagulant Activity of Factor Xa Inhibitors in Patients with Acute Major Bleeding
At Thursday’s DOACs and Beyond: Translational Aspects Oral Communications Session, Janet Leeds, Ph.D. of Portola Pharmaceuticals Inc. presented findings on her research regarding the validation of a pharmacokinetic (PK) and pharmacodynamic (PD) model of andexanet alfa, an investigational agent used for the reversal of anticoagulation with factor Xa (FXa) inhibitor therapie
Interferon-Induced Transmembrane 3 (IFITM3) on Megakaryocytes and Platelets Regulates Fibrinogen Endocytosis and Thrombosis During Inflammation
During Thursday morning’s “Platelets and Inflammation” Oral Communications Session, Robert Campbell, Ph.D., presented his findings on interferon-induced transmembrane 3, or IFITM3—an interferon responsive gene product that restricts pathogen replication
Thursday Headlines Preview – ISTH 2017
There’s nothing like attending an ISTH Congress. But wouldn’t it be great if you could take it home with you? Now you can. Download the new ISTH Academy App . This is your easy, one-stop shop for all your meeting-related educational needs. You’ll receive insider access to select recorded ISTH 2017 presentations. There are also […]
SCIENTIFIC PROGRAM
Factor XI and XII in Blood Clotting and Beyond – Contact Pathway Under Flow
Owen McCarty, Ph.D. presented his research on “Factor XI and XII in Blood Clotting and Beyond: Contact Pathway Under Flow” at Wednesday’s State-of-the-Art Session
Platelets Beyond Thrombosis – Platelets and Their Role as Mediators of Immunity
During Wednesday’s State-of-the-Art Session, Platelets Beyond Thrombosis, John W. Semple, Ph.D. highlighted the attributes of platelets and their precursor cells, megakaryocytes (MK) in their ability to modulate immunity, particularly via their major histocompatibility complex (MHC) class I molecules
Neurobiology and Stroke – Stroke Models: Time for a Compromise
In this State-of-the-Art Session entitled, “Neurobiology and Stroke-Stroke Models: Time for a Compromise”, Denis Vivien, M.D., Ph.D. discussed two stroke models being studied in his laboratory.
Platelets Beyond Thrombosis – Platelets at the Vascular Interface
At Wednesday’s State-of-the-Art Session, “Platelets Beyond Thrombosis”, Wolfgang Bergmeier, Ph.D., presented ISTH attendees with a review of the literature on RAP1 signaling in platelets as well findings from his most recent research
Neurobiology and Stroke – Coagulation and Fibrinolysis at the Neurovascular Interface
Katerina Akassoglou, Ph.D. discussed with attendees at Wednesday’s State-of-the-Art Session her group’s research evaluating fibrin in neurological diseases
Novel Therapies for Hemophilia – Gene Therapy Replacement
During Tuesday’s State-of-the-Art Session “Novel Therapies for Hemophilia”, President and Chief Scientific Officer of Spark Therapeutics, Katherine High, M.D., Ph.D. summarized findings from their phase I/II trial of the long-term safety and efficacy of factor IX (FIX) gene therapy in patients with hemophilia B
Novel Therapies for Hemophilia – Small Molecules in the Treatment of Hemophilia
During yesterday’s State-of-the-Art Session, Steven Pipe, M.D. presented an overview of the current and future state of small molecules in the treatment of hemophilia. These new therapies are very exciting, as they represent a paradigm shift not seen since the advent of the first replacement products and prophylactic therapy.
Stem Cell Engineering – Large-Scale Production of Platelets: A Clinical Perspective
At Tuesday’s State-of-the-Art Session “Stem Cell Engineering”, Cedric Ghevaert, M.D., Ph.D. presented a new approach to the in vitro development of platelets
Current Pathophysiological Concepts of Thrombotic Microangiopathies – New Treatments of TTP
Dr. Cataland describes the role of ADAMTS13 in TTP and presented two important TTP clinical trial
Novel Functions of VWF – VWF in Tumor Thrombophilia and Metastasis
In Monday’s Joint ISTH-WFH State-of-the-Art Session, “Novel Functions of VWF”, Stefan Schneider, M.D. discussed the role of von Willebrand Factor (VWF) in coagulation and its link to cancer
Stem Cell Engineering – Megakaryocyte Matrix Interactions and Platelet Production
At Tuesday’s State-of-the-Art Session, “Stem Cell Engineering”, Alessandra Balduini, M.D. presented her research on megakaryocyte matrix interactions and platelet production
Life and Death of Platelets – Proinflammatory Function of Dying Platelets
During Monday’s State-of-the-Art Session, Shaun Jackson, M.B.B.S., B.Med.Sci., Ph.D. presented his work on “Proinflammatory Function of Dying Platelets”, describing how these platelets are responsible for heterogenous disorders.
What Happens After Acute VTE? – Chronic Thromboembolic Pulmonary Hypertension
Monday’s State-of-the-Art Session, “What Happens After Acute VTE?” included an important discussion about chronic thromboembolic pulmonary hypertension (CTEPH) led by Irene Lang, M.D.
Novel Functions of VWF – VWF and Inflammation
On Monday, during the Joint ISTH-WFH Session on Novel Functions of Von Willebrand factor (VWF), Cecile Denis, M.D. discussed the importance of VWF in inflammation.
What Happens After Acute VTE? – Prevention and Treatment
During Monday’s State-of-the-Art Session titled “What Happens After Acute VTE?”, Arina ten Cate-Hoek, M.D., Ph.D. presented research regarding prevention and management of the post-thrombotic syndrome (PTS)
Past, Present, and Future SSC Chairs Highlight Important Sessions
In preparation for the 63rd Annual Scientific and Standardization Committee Meeting at the ISTH 2017 Congress, we asked the past, present and future SSC Chairmen to pick the most interesting SSC Subcommittee presentations.
Tissue Factor Biology – Tissue Factor Flip-Flopping Between Coagulation and Signaling
Wolfram Ruf, M.D. presented “Tissue Factor Flip-Flopping Between Coagulation and Signaling” at Wednesday’s Plenary Session, providing a detailed assessment of the role of tissue factor (TF) in thrombotic, hemostatic, and immune pathways.
Angiogenesis Revisited: Role and (Therapeutic) Implications of Endothelial Metabolism
Vascular endothelial growth factor and Notch are important in angiogenesis, but what has been largely overlooked is the role and therapeutic potential of endothelial cell (EC) metabolism. In Tuesday’s Fritz Koller Plenary Lecture, Peter Carmeliet, M.D., Ph.D. revealed his key research findings.
Plenary Agenda is Now Available!
AWARDS
Bach Awards
Ten Receive BACH Awards Recognizing High Achievement
ISTH Council Chair Ingrid Pabinger, M.D., announced the ten recipients of the Biennial Awards for Contributions to Hemostasis (BACH) during the Opening Ceremony of the ISTH 2017 Congress.
Grant Medal
Jack Hirsh Awarded the Prestigious Grant Medal at Opening Ceremony
In a video message shown at the Opening Ceremony of the ISTH 2017 Congress, Jack Hirsh, M.D., accepted the Robert P. Grant Medal, the highest award of the ISTH.
Roberts Medal
Sam Schulman Announced as Roberts Medal Recipient for SSC Contributions
At the ISTH 2017 Congress Opening Ceremony, the ISTH announced Sam Schulman, M.D., as the Harold R. Roberts Medal recipient, recognizing contributions to the Scientific and Standardization Committee (SSC).
Featured Video
Late Breaking Results in Hemophilia: Putting the Science to Practice
SOCIAL PROGRAMS
5K Charity Run
Hundreds of Congress Attendees Run for Charity
More than 300 ISTH 2017 Congress attendees participated in the ISTH 2017 5K Charity Run/Walk on Tuesday night in Berlin’s Grunewald forest.
ISTH 2017 5K Charity Run/Walk
Keep Life Flowing – benefiting World Thrombosis Day Tuesday, July 11 at 8 p.m. – Grunewald Register Now The participation fee is 10 EUR and all proceeds will benefit World Thrombosis Day. Join us for the ISTH 2017 5K Charity Run/Walk on Tuesday July 11 at 8 p.m.. Stay fit and help raise awareness and support ISTH’s global World […]
Networking Evening
ISTH 2017 Networking Evening
The ISTH is delighted to invite you to the official ISTH 2017 Congress Networking Evening on Wednesday, July 12 at 19:00. Join us for this exciting event at the visionary and unique Tempodrom where you will have the opportunity to network with friends and colleagues. The evening will feature musical performances from local artists as well as […]
Opening Ceremony & Reception
LATEST UPDATES
Discover the Highlights of ISTH 2017
Watch this video for a brief recap of the Congress, and begin planning to join us in Dublin for the ISTH SSC 2018 meeting, July 18-21, 2018
Apply for an ISTH Training Fellowship to Gain Global Experience
If you wish to study at an institute known for their expertise in thrombosis and hemostasis, apply for an ISTH Training Fellowship
ISTH SSC 2018 President Dermot Cox Invites You to Dublin
Dermot Cox, Ph.D. previews next year’s 2018 ISTH SSC Congress that will take place in his hometown of Dublin, Ireland.
Join the ISTH for a New Education Workshop in Bangkok
You're invited to the ISTH Workshop on Thrombosis and Hemostasis in Bangkok, Thailand. This workshop is designed to offer the latest training in coagulation and bleeding disorders management.
Access Recorded Presentations from the ISTH Academy and Academy App
All ISTH 2017 attendees can access every Plenary and State-of-the-Art session online for free, available 24 hours after presented via the ISTH Academy and ISTH Academy App
Help Break a Guinness World Records Title
Join the ISTH, World Thrombosis Day and Time2Move in an attempt to break a Guinness World Records title for the most people participating in a chair-based exercise class on Wednesday, July 12 at 17:40 in Hall B following the Erwin Deutsch Plenary Lecture
ISTH 2019 President Robert Medcalf Previews the Congress in Melbourne
Robert Medcalf, Ph.D. previews the upcoming 2019 ISTH Congress that will take place in Melbourne, Australia.
JTH Editors Discuss New JTH Editors Awards, New Initiatives
Congratulations to the winners of the 2017 Journal of Thrombosis and Haemostasis Editors’ Awards. Five young first authors of these papers received a travel grant to attend the Congress.
Why is ISTH Membership Important? Featuring ISTH Council Chair Ingrid Pabinger
Ingrid Pabinger, M.D., ISTH Council Chair, explained the importance of ISTH membership and becoming part of the ISTH family. She also described many new advantages and programs ISTH is offering, including their new open access journal Research and Practice in Thrombosis and Haemostasis (RPTH).
World Thrombosis Day Chairman Shares Campaign Impact and What’s Ahead
Gary Raskob, Ph.D., Chair of the Steering Committee for World Thrombosis Day sat down with ISTH TV to talk about the campaign’s efforts to raise global awareness of thrombosis.
Former Reach-the-World Fellow Describes Impact of Program
Dr. Patricia Casais, M.D., Ph.D., a former Reach-The-World Fellow, describes the impact of the program on her career, both professionally and personally.
ISTH 2017 Congress President Johannes Oldenburg Welcomes Attendees
ISTH 2017 Congress President Johannes Oldenburg, M.D., Ph.D. personally welcomed attendees to Berlin. The Congress this year is the largest, most impressive meeting to date, with more than 130 invited speakers, 28 State-of-the-Art Sessions, 8 Plenary Sessions, numerous abstracts and symposia, and more than 550 presentations.
Largest Ever ISTH Congress Begins with Exciting Opening Ceremony
ISTH 2017 Congress President Johannes Oldenburg, M.D., Ph.D., officially opened the Congress with a welcome speech followed by a welcome symphony and video presentation. With more than 9,000 registered attendees, the ISTH 2017 Congress was officially hailed as the largest meeting in the history of the ISTH.
Explore New Educational Offerings in the ISTH Academy
Claire McLintock, M.D., ISTH Secretary/Council Chairman-Elect and the Chair of the ISTH Education Committee, stopped by the ISTH TV studio to tell us more about this exciting educational resource.
ISTH Early Career Task Force Invites Participation, Collaboration
The ECTF consists of a group of 12 early career ISTH members from worldwide origins. The ISTH Early Career Task Force (ECTF) invites early career professionals to connect and collaborate at the ISTH 2017 Congress.
SSC Chair Walter Ageno Recaps ISTH 2017 SSC Sessions
On Sunday, the chairman of the Scientific and Standardization Committee (SSC), Walter Ageno, M.D. discussed the role of the committee within the Congress.
Editor-in-Chief Mary Cushman Applauds Launch of RPTH Journal
Mary Cushman, M.D., M.Sc. presented the launch of the Research and Practice in Thrombosis and Haemostasis (RPTH) journal yesterday. The RPTH journal is an online-only, open-access (non-subscription based) publication.
World Thrombosis Day Builds Awareness and Elevates Impact for the Global Burden of Thrombosis
In Sunday’s education session, “World Thrombosis Day: Building Awareness and Elevating Impact for the Global Burden of Thrombosis,” supporters and activists of the World Thrombosis Day campaign joined together to discuss trending topics, key challenges, and what lies ahead for the campaign.
ISTH Awards Three Reach-the-World Fellowships
In February, the ISTH Education Committee awarded three ISTH members with Reach-the-World Fellowships.
Nurses Committee Chair Maura Malone Discusses Nurses Forum
Maura Malone, MSN, RN highlighted the ISTH Nurses Forum held here at the Congress yesterday. The key areas of focus of the Nurses Forum this year are improving outcomes for patients and families, providing opportunities where nurses can contribute to research, providing education for diverse patient populations (including adolescents), and learning about transitioning care in the clinics.
ISTH 2017 in the Palm of Your Hand: Download the Congress App!
Download the official ISTH 2017 Congress App today and gain access to the program and your personal itinerary on the go. See abstracts, presenters, exhibition information, maps, news and more from the palm of your hand. The ISTH 2017 Congress App is an essential tool to navigate all aspects of the meeting. Click here to […]
New Open Access Journal, RPTH, Publishes Inaugural Issue at ISTH 2017
The ISTH, in partnership with John Wiley and Sons, Inc., announces the launch of the Society’s new open access journal, Research and Practice in Thrombosis and Haemostasis (RPTH), with its inaugural issue to publish in conjunction with the ISTH 2017 Congress.
Plan to Attend the Reach-the-World and WFH Fellowships Symposium
Join the ISTH and the World Federation of Hemophilia (WFH) for a special session, “Building Capacity Globally: The Impact and Future of the RtW and IHTC Programs”
Download the New ISTH Academy App for Education on Demand
Download the new ISTH Academy App today and gain access to select recorded ISTH 2017 presentations, as well as archived webinars and webcasts from previous meetings.
View the ISTH 2017 Abstracts Online
Abstracts are now available as a special compilation from Research and Practice in Thrombosis and Haemostasis (RPTH), the new open access journal of the ISTH. Access abstracts here or view via the online program. Note on Late Breaking Abstracts: Full text of Late Breaking Oral Abstracts will be released via the mobile app and online program after they are presented.
BioMarin Provides BMN 270 Data at International Society on Thrombosis and Haemostasis (ISTH) 2017 Congress
BioMarin Pharmaceutical Inc. announced today an update to its previously reported interim results of an open-label Phase 1/2 study of BMN 270, an investigational gene therapy treatment for severe hemophilia A.
Sobi and Bioverativ highlight commitment to improving care for people with haemophilia at ISTH 2017 congress
Swedish Orphan Biovitrum AB and Bioverativ Inc. today announces that new data from their extended half-life therapies, Alprolix® (eftrenonacog alfa)([Coagulation Factor IX (Recombinant), Fc Fusion Protein] and Elocta® (efmoroctocog alfa), marketed as ELOCTATE® [Antihemophilic Factor (Recombinant), Fc Fusion Protein]) in the United States, Japan and Canada, will be presented at the International Society on Thrombosis […]
Octapharma activities prominent at the upcoming 2017 ISTH Congress in Berlin, Germany
Octapharma today announced that it will be actively involved in a wide range of activities at this year’s International Society on Thrombosis and Haemostasis (ISTH) Congress.
Thrombosis Research Institute is to Unveil First Results from the GARFIELD-VTE Registry at the ISTH 2017 Congress
The first results from the Global Anticoagulant Registry in the Field - Venous Thromboembolism (GARFIELD-VTE) will be presented at the International Society of Thrombosis and Haemostasis Congress 2017, to be held in Berlin, Germany, from July 8th to 13th.
New Data from Bayer’s Portfolio in Thrombosis and Hemophilia to be Presented at ISTH 2017
Bayer AG announced today that new data from its portfolios in thrombosis and hematology will be presented at the International Society on Thrombosis and Haemostasis (ISTH) 26th Biennial Congress and 63rd Annual Scientific and Standardization Committee (SSC) Meeting, which will take place in Berlin, Germany, from July 8 to 13.
Novo Nordisk to Present 35 Abstracts at the International Society on Thrombosis and Haemostasis Congress
Novo Nordisk announced today that data from 35 abstracts will be presented at the upcoming International Society on Thrombosis and Haemostasis (ISTH) congress from 8-13 July, in Germany.
Visit Supported Symposia and Product Theaters for Latest Updates
Complementing an exciting and innovative scientific program, ISTH 2017 features the latest diagnostic and therapeutic updates from the leading companies in the field of thrombosis and hemostasis.
uniQure Announces Clinical Data Presentations at the Upcoming International Society on Thrombosis and Hemostasis (ISTH) Congress
uniQure N.V., a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that two abstracts have been accepted for presentation at the International Society on Thrombosis and Hemostasis (ISTH) Congress held in Berlin, Germany, July 8 - 13, 2017.
Stago Group Acquires HemoSonics LLC
The Stago Group announced today that it has completed the acquisition of HemoSonics LLC, a company specialized in the development of innovative Point-of-Care testing solutions based in Charlottesville, VA, with facilities in Durham, NC (USA).
Shire to Present New Data at ISTH 2017 to Advance the Standard of Care in Hemophilia
Shire plc, a leading biotechnology company focused on serving individuals with rare diseases, will present research covering a broad range of rare bleeding disorders at the 26th Biennial International Society on Thrombosis and Haemostasis Congress (ISTH), July 8-13, 2017 in Berlin, Germany.
Spark Therapeutics to Present Updated Hemophilia B Data at the International Society on Thrombosis and Haemostasis (ISTH) 2017 Congress
Spark Therapeutics, a fully integrated gene therapy company dedicated to challenging the inevitability of genetic disease, announced today that Lindsey George, M.D., attending physician in the Division of Hematology at Children's Hospital of Philadelphia, and a clinical investigator in the Phase 1/2 clinical trial of SPK-9001 for hemophilia B, will present updated interim data at the International Society on Thrombosis and Haemostasis (ISTH) 2017 Congress in Berlin.
Roche’s Emicizumab Showed Positive Results in Phase III Studies (HAVEN 1 and HAVEN 2) in Haemophilia A with Inhibitors
Emicizumab showed substantial and clinically meaningful reduction in bleeds across two pivotal studies. Data from HAVEN 1 in adults and adolescents and interim data from HAVEN 2 in children to be presented at the 26th International Society on Thrombosis and Haemostasis (ISTH) Meeting
Catalyst Biosciences Announces Presentations on its Next-Generation Subcutaneous Hemophilia Product Candidates at the 2017 International Society on Thrombosis and Haemostasis (ISTH) Meeting
Catalyst is focused on the prevention of bleeding in individuals with hemophilia through the development of clotting factors that may be injected subcutaneously, rather than intravenously, potentially achieving normal coagulation activity.
